Literature DB >> 24247322

Parkinson disease: Pimavanserin could be useful for treating psychosis in Parkinson disease.

Katie Kingwell.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24247322     DOI： 10.1038/nrneurol.2013.233

Source DB:  PubMed          Journal:  Nat Rev Neurol        ISSN： 1759-4758            Impact factor:   42.937


× No keyword cloud information.
  1 in total

1.  Pimavanserin for patients with Parkinson's disease psychosis: a randomised, placebo-controlled phase 3 trial.

Authors:  Jeffrey Cummings; Stuart Isaacson; Roger Mills; Hilde Williams; Kathy Chi-Burris; Anne Corbett; Rohit Dhall; Clive Ballard
Journal:  Lancet       Date:  2013-11-01       Impact factor: 79.321
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.